Compare Izumi Finance (IZI) vs Enzyme (MLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Izumi Finance vs Enzyme — how do they compare? Izumi Finance trades at Rp26.85 (market cap Rp32,06M, Rp254,85jt 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Enzyme is far larger — about 4.2× Izumi Finance's market cap, and Izumi Finance's supply is capped (787,4M / 2B IZI (40%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Izumi Finance for 11 Days and Enzyme for 29 Days on average.
| IZI | MLN | |
|---|---|---|
Market Cap | Rp32,06M | Rp134,13M |
Volume (24h) | Rp254,85jt | Rp104,56M |
Circulating Supply | 787,4M / 2B IZI (40%) | 3,3M MLN |
Typical Hold Time | 11 Days | 29 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Izumi Finance (IZI) shows limited market activity with a modest market cap of Rp32.06M and 40% token circulation. The token exhibits typical crypto volatility with an average hold time of 11 days, indicating short-term trading patterns. No recent protocol updates or significant ecosystem developments have been observed, suggesting quiet network activity.
Overall outlook remains cautious due to low liquidity and limited market presence. Key opportunities include potential ecosystem growth if development resumes, while major risks include high volatility, regulatory uncertainty, and low trading volume affecting price stability.
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
About Izumi Finance
Izumi Finance provides Programmable Liquidity as a Service (LaaS) on Ethereum with Uniswap V3 and plans to expand to multiple chains with integrated DEXs. This service allows liquidity providers to earn extra liquidity mining rewards and trading fees. It also helps protocols attract and maintain liquidity effectively. Izumi improves incentive distribution through its LiquidBox, allowing rewards to be allocated within specific price ranges.
Read more on IZI →About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →
